{"id":"W2063627867","doi":"10.1016/j.jaad.2007.09.010","title":"Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":883,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Adalimumab; Psoriasis; Randomized controlled trial; Dermatology; Physical therapy; Internal medicine; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02011710880311059,"score_gpt":0.3155302584066383,"score_spread":0.2954131496035277,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}